𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cerebrospinal fluid analysis for Whipple's disease in patients with progressive supranuclear palsy

✍ Scribed by Francesca Romana Pezzella; Maria Grazia Paglia; Carlo Colosimo

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
542 KB
Volume
19
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

The clinical picture of neurological involvement in Whipple's disease (WD) may resemble progressive supranuclear palsy (PSP). We looked for WD pathogen DNA in the cerebrospinal fluid of 9 patients with a clinical diagnosis of PSP. The analysis was negative for all samples, showing that WD is not commonly involved in the aetiopathogenesis of PSP.

📜 SIMILAR VOLUMES

Cerebrospinal fluid Aβ42 is reduced in m
Cerebrospinal fluid Aβ42 is reduced in multiple system atrophy but normal in Parkinson's disease and progressive supranuclear palsy
✍ Björn Holmberg; Bo Johnels; Kaj Blennow; Lars Rosengren 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract The 42‐amino–acid isoform of β‐amyloid Aβ42 in the cerebrospinal fluid (CSF) has recently been proposed as a biochemical marker for Alzheimer's disease (AD) and subcortical white‐matter dementia (SWD). In both of these conditions, concentration of CSF‐Aβ42 is reduced. We quantified CSF‐

Decrease of serotonin-S2 receptors in te
Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy
✍ Dr. J. M. Maloteaux; E. C. Laterre; P. M. Laduron; F. Javoy-Agid; Y. Agid 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 544 KB

The number of serotonin-S, receptors was decreased in the temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy (PSP). There was no significant modification of these receptors in the frontal cortex or in the hippocampus and putamen in both diseases. The decrease in